Clinical Trial Update: Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating same-day dosing of pegfilgrastim in breast cancer patients undergoing TAC chemotherapy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer, Fever | Phase 2 | Status: COMPLETED